Josie Robertson Investigators

Share
Print
Share
Print

Josie Robertson Investigators are appointed to five-year terms.

2020–2025

Chemical Biology Program
Heeseon An, PhD
Heeseon An’s lab develops chemical, biological, and proteomics tools to study protein homeostasis of sub-cellular organelles.
Human Oncology & Pathogenesis Program
Chrysothemis Brown, MBBS, PhD
The Brown Lab studies how the tissue environment shapes immune cell fate and function during early life immune development, inflammation, and cancer.

2019–2024

Molecular Pharmacology Program
The Karuna Ganesh Lab
Karuna Ganesh, MD, PhD
Physician-scientist Karuna Ganesh studies stem cell plasticity in metastasis, therapy resistance and tissue regeneration.
Computational & Systems Biology Program
Thomas Norman, PhD
Systems biologist Thomas Norman develops new computational and functional genomics approaches for studying how genes interact to realize complex phenotypes.

2018–2023

Human Oncology & Pathogenesis Program
Samuel Bakhoum Lab Group
Samuel Bakhoum, MD, PhD
Physician-scientist Samuel Bakhoum studies the role of chromosomal instability in tumor evolution and metastasis.
Developmental Biology Program
The Thomas Vierbuchen Lab
Thomas S. Vierbuchen, PhD
The Vierbuchen laboratory directs the differentiation of mouse and human pluripotent stem cells to characterize fundamental mechanisms of neuronal cell fate specification and function.

2017–2022

Structural Biology Program
Hite Lab Group
Richard Hite, PhD
The Hite laboratory studies the mechanisms of intracellular ion transport.
Cancer Biology & Genetics Program
Tuomas Tammela Lab
Tuomas Tammela, MD, PhD
Cancer biologist Tuomas Tammela investigates cellular heterogeneity in lung, pancreatic and colon cancers.

2016–2021

Chemical Biology Program
The Yael David Lab
Yael David, PhD
Yael David’s lab develops and applies methods in chemical biology toward studying epigenetic regulation and its correlation with disease states.
Human Oncology & Pathogenesis Program
The Piro Lito Lab
Piro Lito, MD, PhD
Physician-scientist Piro Lito studies oncoproteins that drive cancer cell growth.

2015–2020

Chemical Biology Program
The Daniel Bachovchin Lab Group Photo
Daniel Bachovchin, PhD
Chemical biologist Daniel Bachovchin designs selective inhibitors to study enzymes and pathways in cancer and immune system signaling.
Memorial Hospital Research Laboratories
The Elli Papaemmanuil Lab
Elli Papaemmanuil, PhD
Molecular geneticist Elli Papaemmanuil performs systematic interrogations of well-annotated clinical trial cohorts in leukemia and cancer to explore how the compound genetic and clonal architecture in patients' leukemias and tumors dictate clinical phenotype, disease progression, and clinical outcomes.
Alumni

2014–2019

Immunology Program
Andrea Schietinger lab
Andrea Schietinger, PhD
Cancer Immunologist Andrea Schietinger investigates immune responses to cancer, molecular mechanisms underlying tumor-induced T cell dysfunction, and new approaches for cancer immunotherapy.

2013–2018

Molecular Pharmacology Program
The Alex Kentsis Lab
Alex Kentsis, MD, PhD
Cancer biologist and pediatric oncologist Alex Kentsis leads research in the functional proteomics and molecular pharmacology of refractory childhood cancers.
Human Oncology & Pathogenesis Program
Nikolaus Schultz Lab
Nikolaus Schultz, PhD
Cancer biologist Nikolaus Schultz uses computational tools to study the diversity of genomic alterations underlying different cancer types.

2012–2017

Human Oncology & Pathogenesis Program
The Omar Abdel-Wahab Lab
Omar Abdel-Wahab, MD
Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.
Cancer Biology & Genetics Program
Richard White Lab
Richard White, MD, PhD
Cancer biologist and oncologist Richard White uses the zebrafish to dissect interactions between tumor cells and the microenvironment that promote metastasis.